• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Gulyas Diane H. was granted 1,904 shares, increasing direct ownership by 15% to 14,788 units (SEC Form 4)

    5/1/26 6:12:47 PM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Gulyas Diane H.

    (Last)(First)(Middle)
    4920 O'HEAR AVE
    SUITE 400

    (Street)
    NORTH CHARLESTON SOUTH CAROLINA 29405

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Ingevity Corp [ NGVT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    04/30/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Common Stock04/30/2026A1,904(1)A$014,788D
    Common Stock3,747IBy trust(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.
    2. Held through the Diane H. Gulyas Trust, of which the reporting person is trustee and the reporting person's spouse is beneficiary.
    Remarks:
    Diane H. Gulyas By: Mavis G. Huger as Attorney-in-Fact05/01/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $NGVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Ingevity Corporation

    SCHEDULE 13G/A - Ingevity Corp (0001653477) (Subject)

    5/15/26 7:34:39 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form S-8 filed by Ingevity Corporation

    S-8 - Ingevity Corp (0001653477) (Filer)

    5/7/26 5:10:02 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Ingevity Corporation

    10-Q - Ingevity Corp (0001653477) (Filer)

    5/7/26 4:26:06 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dentsply Sirona Appoints John Fortson as Chief Financial Officer

    CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20. Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-sc

    6/11/26 8:30:00 AM ET
    $NGVT
    $XRAY
    Major Chemicals
    Industrials
    Medical/Dental Instruments
    Health Care

    Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference

    Ingevity Corporation (NYSE:NGVT) today announced that Dave Li, president and CEO, and Phillip Platt, senior vice president and CFO, will participate in a fireside chat during the 2026 Wells Fargo 16th Annual Industrials & Materials Conference on Thursday, June 11, at 10:30 a.m. ET. Ingevity invites investors and interested parties to access the live webcast via the following link: Industry & Materials Industry Conference - Wells Fargo. An audio replay and transcript will be available following the event on the Events and Presentations section of Ingevity's investor relations website. For additional information on the conference, visit: https://www.wellsfargo.com/cib/insights/events/indu

    6/9/26 5:21:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity reports first quarter 2026 financial results

    First Quarter 2026 Results & Recent Highlights: Net sales of $258.0 million increased 4% from prior year Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties product line on Janua

    5/6/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief HR Officer Dyer Terrance M sold $33,971 worth of shares (496 units at $68.49), decreasing direct ownership by 6% to 7,202 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    6/1/26 2:03:54 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SVP, Finance & CAO Platt Phillip John was granted 1,262 shares, increasing direct ownership by 4% to 31,633 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    5/5/26 5:23:32 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Director Fernandez-Moreno Luis M was granted 1,904 shares, increasing direct ownership by 5% to 37,882 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    5/1/26 6:14:25 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints John Fortson as Chief Financial Officer

    CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20. Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-sc

    6/11/26 8:30:00 AM ET
    $NGVT
    $XRAY
    Major Chemicals
    Industrials
    Medical/Dental Instruments
    Health Care

    Ingevity announces key leadership transitions

    Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity names Ruth Castillo as senior vice president and president of Performance Materials

    Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili

    10/23/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingevity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

    2/26/25 7:15:06 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by CJS Securities with a new price target

    CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

    8/7/24 9:18:13 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by Jefferies with a new price target

    Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

    4/22/24 7:39:26 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Financials

    Live finance-specific insights

    View All

    Ingevity reports first quarter 2026 financial results

    First Quarter 2026 Results & Recent Highlights: Net sales of $258.0 million increased 4% from prior year Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties product line on Janua

    5/6/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    PPG acquires pavement markings manufacturer Ozark Materials, LLC

    PPG (NYSE:PPG) today announced that it has completed the acquisition of Ozark Materials, LLC, a U.S.-based provider of pavement marking solutions, from Ingevity Corporation (NYSE:NGVT). The all-cash transaction includes a purchase price of $65 million, subject to customary adjustments. Ozark Materials serves customers across the United States and Canada and has a strong reputation for quality, service and operational excellence. The company has approximately 130 employees and well-established customer relationships that align closely with PPG's Traffic Solutions business. "This acquisition strengthens our business by enhancing our ability to serve customers throughout North America with

    4/15/26 4:30:00 PM ET
    $NGVT
    $PPG
    Major Chemicals
    Industrials
    Paints/Coatings
    Consumer Discretionary

    Ingevity announces dates for first quarter 2026 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its first quarter 2026 earnings after the stock market close on Wednesday, May 6, 2026. The company will host a live webcast on Thursday, May 7, at 10:00 a.m. (Eastern) to discuss first quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 616645588. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (

    4/8/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/12/24 3:54:24 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/4/24 11:52:25 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

    SC 13D/A - Ingevity Corp (0001653477) (Subject)

    2/28/24 5:30:32 PM ET
    $NGVT
    Major Chemicals
    Industrials